Search

COVID-19 low cost medicine approved for use in India

The Central government has approved the use of low-cost steroid medicine dexamethasone for the treatment of COVID-19 patients in India. This drug will be used only to treat patients with severe symptoms. British clinical trials had earlier found Dexamethasone to be effective against severely ill COVID-19 patients.

 

The World Health Organisation (WHO) has already called for an increase in the production of Dexamethasone. The WHO has, however, also warned that the drug should be used under strict medical supervision and only to treat severe patients

Admin Login by RSP

Admin Login by Center Team

Dear Visitors !

Articles written by authors are their views and their presentation of ideas and knowledge. CHEARS does not claim right on write-up and authors are the real owner and are responsible for their write-up or views. Posts from CHEARS News Room are interpretations or presentation of news from various news resources. 

Posts from executive committee members are posts from CHEARS Office.  

© Center for Health Education, Awareness Resources and Services

Subscribe to Our Newsletter